Manganese sulfate monohydrate
-
Manganese sulfate monohydrate
structure -
-
CAS No:
10034-96-5
-
Formula:
H2O4S.H2O.Mn
-
Chemical Name:
Manganese sulfate monohydrate
-
Synonyms:
Sulfuric acid,manganese(2+) salt,hydrate (1:1:1);Sulfuric acid,manganese(2+) salt (1:1),monohydrate;Manganese mesosulfate (MnSO4.H2O);Manganese sulfate (MnSO4) monohydrate;Manganese(2+) sulfate monohydrate;Manganese sulfate monohydrate;Manganese monosulfate monohydrate;Sulfuric acid manganese salt (1:1) monohydrate;Manganous sulfate monohydrate;Manganese(II) sulfate monohydrate;2360969-81-7;2485018-50-4
-
Categories:
Active Pharmaceutical Ingredients > Vitamins and Minerals Medicines
-
CAS No:
Description
PINK HYGROSCOPIC CRYSTALS.
Manganese(ii) sulfate monohydrate appears as odorless pale red slightly efflorescent crystals or light pink powder. pH (5% solution) 3.7. (NTP, 1992)|PINK HYGROSCOPIC CRYSTALS.
Manganese(ii) sulfate monohydrate appears as odorless pale red slightly efflorescent crystals or light pink powder. pH (5% solution) 3.7. (NTP, 1992)|Manganese(II) sulfate monohydrate is a hydrate that is the monohydrate form of manganese(II) sulfate. It has a role as a nutraceutical. It is a hydrate, a manganese molecular entity and a metal sulfate. It contains a manganese(II) sulfate.
Manganese sulfate monohydrate Basic Attributes
169.02
168.900345
232-089-9
W00LYS4T26
0290
3077
DTXSID4020795
28332990
Characteristics
89.6
-0.32150
Pink Solid
2.95 g/cm3
700 °C
850 °C
H2O: 5-10 g/100 mL at 21 ºC
Store at RT.
3.35E-05mmHg at 25°C
Combustible, the fire emits manganese, sulfur oxides and spicy irritating smoke
Water soluble. Hygroscopic.
Salts, Acidic
MANGANESE(II) SULFATE MONOHYDRATE is incompatible with aluminum and magnesium. (NTP, 1992)
Safety Information
Ⅲ
9
UN 3077 9/PG 3
1
48/20/22-51/53
22-61
OP0893500
Xn,N
Warehouse low temperature, ventilated, dry
Stable under normal temperatures and pressures.
P273
H373-H411
Flash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)|Not combustible. Gives off irritating or toxic fumes (or gases) in a fire.
|Warning|H373 (99.87%): Causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]|P260, P273, P314, P391, and P501|Aggregated GHS information provided by 1572 companies from 15 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|H373 (100%): Causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]|Aggregated GHS information provided by 42 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.|Danger|H302: Harmful if swallowed [Warning Acute toxicity, oral]|P260, P264, P270, P280, P301+P312, P305+P351+P338, P310, P314, P330, and P501|H341: Suspected of causing genetic defects [Warning Germ cell mutagenicity]|P201, P202, P281, P308+P313, P405, and P501|P201, P202, P260, P264, P270, P280, P281, P301+P312, P305+P351+P338, P308+P313, P310, P314, P330, P405, and P501
Fires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. A water spray may also be used. (NTP, 1992)|In case of fire in the surroundings, use appropriate extinguishing media.
Excerpt from ERG Guide 171 [Substances (Low to Moderate Hazard)]: As an immediate precautionary measure, isolate spill or leak area in all directions for at least 50 meters (150 feet) for liquids and at least 25 meters (75 feet) for solids. SPILL: Increase, in the downwind direction, as necessary, the isolation distance shown above. FIRE: If tank, rail car or tank truck is involved in a fire, ISOLATE for 800 meters (1/2 mile) in all directions; also, consider initial evacuation for 800 meters (1/2 mile) in all directions. (ERG, 2016)
SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned. STORAGE PRECAUTIONS: You should store this chemical under ambient temperatures, and protect it from moisture. If possible, it would be prudent to store this compound under inert atmosphere. (NTP, 1992)
RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)
Personal protection: particulate filter respirator adapted to the airborne concentration of the substance. Do NOT let this chemical enter the environment. Sweep spilled substance into covered containers. If appropriate, moisten first to prevent dusting. Wash away remainder with plenty of water. Store and dispose of according to local regulations.
Dry. Well closed. Store in an area without drain or sewer access.
Evaporation at 20 °C is negligible; a harmful concentration of airborne particles can, however, be reached quickly when dispersed, especially if powdered.
The substance is irritating to the eyes.
The substance may have effects on the central nervous system. Animal tests show that this substance possibly causes toxicity to human reproduction or development.
PREVENT DISPERSION OF DUST!
Use local exhaust or breathing protection.
Protective gloves.
Wear safety spectacles or eye protection in combination with breathing protection if powder.
Drug Information
SYMPTOMS: Symptoms of exposure to this compound include mild irritation of the eyes and mucous membranes of the respiratory tract. Symptoms of exposure to this type of compound include apathy, anorexia, headache, recurring leg cramps, loss of balance, clumsiness, pneumonia and associated pulmonary problems. Other symptoms include central nervous system damage, pulmonary system damage, upper respiratory infections, languor, sleepiness, weakness in the legs, a stolid, mask-like face, muscular twitchings, varying from a fine tremor of the hands to coarse, rhythmical movements of the arms, legs and trunk; slight increase in tendon reflexes, ankle and patellar clonus, typical Parkinsonian slapping gait and minute handwriting (affected by micrographia). It can cause spastic gait, insomnia, dystonia, fatiguability, asthenia and an inability to concentrate. It can also cause impaired mentation, ataxia, difficulty in walking and decreased movement of the eyelids and eyes. Other symptoms include lethargy, edema, extrapyramidal effects, sleep disturbances, dermatitis, irritability, liver enlargement, increased muscle tone, muscular cramps, mental deterioration, excessive salivation and perspiration, sexual disturbances, blood changes and, very rarely, hypothyroidism. Exposure can cause spasms, arthralgias and speech disturbances such as slurred speech, slow and monotonous voice tone, inability to speak above a whisper, difficult articulation and incoherence, and even complete muteness. Psychosis may occur with unaccountable laughter, euphoria, impulsive acts, absentmindedness, mental confusion, aggressiveness and hallucinations. Propulsion, retropropulsion and lateropropulsion are affected with no movement for protection when falling. Absolute detachment may occur, broken by sporadic or spasmodic laughter. Inhalation may cause acute bronchitis, nasopharyngitis and itching. Numbness of the extremities and impairment of libido may occur. Other effects include weakness, delusions, compulsions, rigidity, bradykinesia, sudden crying, stuttering, hoarse voice, nervousness, inability to walk backward, hyporeflexia, Romberg's sign, adiadochokinesia, forgetfulness, general malaise, drowsiness, stiffness of the arms or legs, urinary difficulty, somnolence, sexual excitement followed by impotence, "hen's gait" and frequent falling. Fever may occur, with chills, upset stomach (nausea), vomiting, dryness of the throat, cough and body aches. Other symptoms include trouble with memory and judgment, unstable emotions, incoordination, chest pain, restlessness, double vision, impaired hearing, anemia, lassitude and low back pain. Symptoms of exposure may simulate progressive bulbar paralysis, post-encephalitic Parkinsonism, multiple sclerosis, amyotrophic lateral sclerosis and progressive lenticular degeneration (Wilson's Disease). ACUTE/CHRONIC HAZARDS: When heated to decomposition this compound emits toxic fumes of sulfur oxides. (NTP, 1992)
EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop. SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment. INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing. INGESTION: DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)
Fresh air, rest.
Rinse with plenty of water for several minutes (remove contact lenses if easily possible).
manganese sulfate
The substance can be absorbed into the body by inhalation of its aerosol and by ingestion.
Cough. Sore throat. Shortness of breath.
Redness. Pain.
Manganese sulfate monohydrate Use and Manufacturing
Mix manganese ore and white coal powder with MnO2 content of more than 65% at a ratio of 100:20 (mass ratio), and roast at 700-850°C in a reduction roaster to obtain manganese monoxide. After cooling, MnO is acidolyzed in 15% sulfuric acid to control PH<5.2, the acidolysis solution is adjusted to PH=3-4, metered barium sulfide is added to remove heavy metals, and the hydroxide precipitate and slag are removed by pressure filtration. After standing for 48h, filter again to remove impurities. The filtrate is finally concentrated, crystallized, separated and dried by hot air to obtain manganese sulfate.
Manganese(II) sulfate is used to produce manganese by an electrolytic process. The compound is used for dyeing textiles; for producing red glazes on porcelain; in varnish driers; in fertilizers; and in animal feeds to provide manganese as an essential trace element.
Computed Properties
Molecular Weight:169.02
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:5
Exact Mass:168.900337
Monoisotopic Mass:168.900337
Topological Polar Surface Area:89.6
Heavy Atom Count:7
Complexity:62.2
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Manganese is a component of many metalloenzymes and an enzyme activator. Manganese depletion is associated with a significant decrease in soft tissue chondroitin sulfate.
Registered Holders
-
METROCHEM API PRIVATE LTD
Active
United States
-
MAITHRI DRUGS PRIVATE LTD
Active
United States
-
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
Active
United States
Recommended Suppliers of Manganese sulfate monohydrate
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
5 YRS
Business licensedTrader Supplier of Pharmaceuticals,Peptide,Cosmetics,Nutritional SupplementsInquiryCAS No.: 10034-96-5Grade: Pharmaceutical GradeContent: 99.5% -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Agrochemical productsInquiryCAS No.: 10034-96-5Grade: Industrial GradeContent: 98% -
CN
6 YRS
Business licensedDistributor Supplier of Furan Resin,Furfuryl Alcohol,Furfural,THFA,2-Methyl FuranInquiryCAS No.: 10034-96-5Grade: Industrial GradeContent: 98% -
IN
5 YRS
Business licensed Verified SupplierTrader Supplier of Stearate,Pine Oil,Talc,Magnesium Chloride,Ferric Chloride Liquid/Anhydrous,Calcium Chloride,Feldspar
Learn More Other Chemicals
-
3H-Pyrazol-3-one, 4,5-diamino-1,2-dihydro-, sulfate (1:1)
97358-51-5
-
Pyridine, 2,5-dibromo-, sulfate (1:1)
84473-61-0
-
Benzenemethanaminium, N,N-dimethyl-N-(phenylmethyl)-, methyl sulfate (1:1)
74070-70-5
-
4H-1,2,4-Triazolium, 5-[2-[4-[bis(phenylmethyl)amino]phenyl]diazenyl]-1,4-dimethyl-, methyl sulfate (1:1) Formula
72919-81-4
-
Benzenediazonium, 2-methoxy-4-(phenylamino)-, sulfate (1:1) Formula
36305-05-2
-
Pyridinium, 1-[2-[[4-[2-(2,6-dichloro-4-nitrophenyl)diazenyl]phenyl]ethylamino]ethyl]-, sulfate (1:1) Formula
64086-81-3
-
Benzenaminium, 4-[2-[[4-[2-[2,5-dichloro-4-[(dimethylamino)sulfonyl]phenyl]diazenyl]phenyl]ethylamino]ethoxy]-N,N,N-trimethyl-, methyl sulfate (1:1) Structure
84041-75-8
-
Benzenaminium, 4-[[[(3,4-dichlorophenyl)amino]carbonyl]amino]-N,N,N-trimethyl-, methyl sulfate (1:1) Structure
93777-84-5
-
What is Benzoic acid, 3-hydroxy-4,5-dimethoxy-, 2-(aminoiminomethyl)hydrazide, sulfate (2:1) (salt)
35607-24-0
-
What is Acridinium, 3,6-diamino-10-methyl-, sulfate (1:1)
101952-51-6